Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, central nervous system, anti-cancer/oncology, multiple sclerosis, immunosuppressants, and specialty molecules; and biosimilars products for oncology, diabetes, and immunology therapeutic areas. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal health, consumer goods, and specialty chemical industries, as well as academic institutions, non-profit organizations, and government agencies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Low
337.05
High
447.15
Low
411.00
High
416.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Biocon Limited stacks up against its Biotechnology peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BIOCON Biocon Limited | 413.45 | 0.23% | 122.40 | 3.38 | 67,344 | 0.00% | 3.40% | 447.15 / 337.05 |
| 2 | ANTHEM ANTHEM BIOSCIENCES LTD | 869.50 | 0.57% | 85.45 | 10.18 | 48,970 | 16.40% | 18.92% | 904.00 / 579.15 |
| 3 | BLUEJET Blue Jet Healthcare Limited | 595.05 | 0.04% | 43.93 | 13.55 | 11,263 | 0.00% | 41.99% | 784.00 / 325.00 |
| 4 | CONCORDBIO Concord Biotech Limited | 1,560.00 | 1.06% | 59.30 | 26.31 | 16,320 | 15.47% | 17.81% | 1,801.90 / 987.00 |
| 5 | DCAL Dishman Carbogen Amcis Limited | 173.01 | 0.35% | 167.97 | 1.03 | 2,713 | 11.73% | 34.65% | 321.95 / 128.50 |
| 6 | ONESOURCE ONESOURCE SPECL PHARMA L | 1,532.10 | 0.16% | 0.00 | -4.25 | 17,569 | 8.87% | 23.22% | 1,925.00 / 1,057.00 |
| 7 | PANACEABIO Panacea Biotec Limited | 410.00 | 0.88% | 0.00 | -1.16 | 2,511 | 25.02% | 4.45% | 647.00 / 292.40 |
| 8 | SUPRIYA Supriya Lifescience Limited | 806.20 | 0.68% | 32.71 | 24.65 | 6,489 | 4.70% | 13.27% | 1,085.00 / 545.50 |
| 9 | ZOTA Zota Health Care Limited | 1,087.00 | 0.96% | 0.00 | -31.41 | 3,765 | 0.00% | 10.46% | 1,740.00 / 1,026.20 |